Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML – biolegacy

Syros Pharma To Present Biomarker Data From Ongoing Phase 2 Clinical Trial Of SY-1425 At Conference On AML

Post author:Sam
Post published:September 28, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace